EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy

Asim Kumar Bepari iD, Swakkhar Shatabda iD, Hasan Mahmud Reza iD

PeerJ · 22.01.2024 · 12 · e16762

DOI: 10.7717/peerj.16762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 22.01.2024. Verfasst von Asim Kumar Bepari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, North South University, Dhaka, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Flavonoids, Quality of Life. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United International University and North South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Global prevalence of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease is increasing gradually, whereas approvals of successful therapeutics for central nervous system disorders are inadequate. Accumulating evidence suggests pivotal roles of the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in modulating neuroinflammation and necroptosis. Discoveries of potent small molecule inhibitors for RIPK1 with favorable pharmacokinetic properties could thus address the unmet medical needs in treating neurodegeneration.

Methods

In a structure-based virtual screening, we performed site-specific molecular docking of 4,858 flavonoids against the kinase domain of RIPK1 using AutoDock Vina. We predicted physicochemical descriptors of the top ligands using the SwissADME webserver. Binding interactions of the best ligands and the reference ligand L8D were validated using replicated 500-ns Gromacs molecular dynamics simulations and free energy calculations.

Results

From Vina docking, we shortlisted the top 20 flavonoids with the highest binding affinities, ranging from −11.7 to −10.6 kcal/mol. Pharmacokinetic profiling narrowed down the list to three orally bioavailable and blood-brain-barrier penetrant flavonoids: Nitiducarpin, Pinocembrin 7-O-benzoate, and Paratocarpin J. Next, trajectories of molecular dynamics simulations of the top protein-ligand complexes were analyzed for binding interactions. The root-mean-square deviation (RMSD) was 1.191 Å (±0.498 Å), 1.725 Å (±0.828 Å), 1.923 Å (±0.942 Å), 0.972 Å (±0.155 Å) for Nitiducarpin, Pinocembrin 7-O-benzoate, Paratocarpin J, and L8D, respectively. The radius of gyration (Rg) was 2.034 nm (±0.015 nm), 2.0.39 nm (± 0.025 nm), 2.053 nm (±0.021 nm), 2.037 nm (±0.016 nm) for Nitiducarpin, Pinocembrin 7-O-benzoate, Paratocarpin J, and L8D, respectively. The solvent accessible surface area (SASA) was 159.477 nm 2 (±3.021 nm 2 ), 159.661 nm 2 (± 3.707 nm 2 ), 160.755 nm 2 (±4.252 nm 2 ), 156.630 nm 2 (±3.521 nm 2 ), for Nitiducarpin, Pinocembrin 7-O-benzoate, Paratocarpin J, and L8D complexes, respectively. Therefore, lower RMSD, Rg, and SASA values demonstrated that Nitiducarpin formed the most stable complex with the target protein among the best three ligands. Finally, 2D protein-ligand interaction analysis revealed persistent hydrophobic interactions of Nitiducarpin with the critical residues of RIPK1, including the catalytic triads and the activation loop residues, implicated in the kinase activity and ligand binding.

Conclusion

Our target-based virtual screening identified three flavonoids as strong RIPK1 inhibitors, with Nitiducarpin exhibiting the most potent inhibitory potential. Future in vitro and in vivo studies with these ligands could offer new hope for developing effective therapeutics and improving the quality of life for individuals affected by neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsQuality of LifeHumansMolecular Docking SimulationLigandsBenzoatesReceptor-Interacting Protein Serine-Threonine Kinases

Stichwörter der Autor:innen

AutoDock vinaBioinformaticsComputationalDockingDrug discoveryFlavonoidGromacsKinaseMolecular dynamicsSimulation

Substanzen

FlavonoidsLigandsBenzoatesRIPK1 protein, humanReceptor-Interacting Protein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, North South University, Dhaka, Dhaka, Bangladesh.
  • Department of Computer Science and Engineering, United International University, Dhaka, Dhaka, Bangladesh.

ORCID-Profile: Asim Kumar Bepari, Swakkhar Shatabda, Hasan Mahmud Reza

Förderung

  • United International University and North South University

Zitieren

APA

Bepari, A. K., Shatabda, S., & Reza, H. M. (2024). Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy. PeerJ, 12, e16762. https://doi.org/10.7717/peerj.16762

Vancouver

Bepari AK, Shatabda S, Reza HM. Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy. PeerJ. 2024;12:e16762. doi:10.7717/peerj.16762

BibTeX
@article{Bepari2024,
  author = {Bepari, Asim Kumar and Shatabda, Swakkhar and Reza, Hasan Mahmud},
  title = {Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy},
  journal = {PeerJ},
  year = {2024},
  volume = {12},
  pages = {e16762},
  doi = {10.7717/peerj.16762}
}
Kostenlos starten →